Nuclear medicine production at ANSTO
Ongoing media statements relating to nuclear medicine production.
Showing 1 - 20 of 33 results
Ongoing media statements relating to nuclear medicine production.
See details of previously published customer updates from our Health products team.
An investment that will secure the long term sustainability of nuclear medicine supply in Australia.
Australia’s new state-of-the-art nuclear medicine facility gets green light.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.
Nuclear medicine generator production to resume next week
The instrument is designed to measure inelastic neutron scattering, or do neutron spectroscopy.
Dr Inna Karatchevtseva undertakes work at ANSTO in two main areas: defence industry research and fundamental materials research.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.
ANSTO’s FutureNow Scholarships support graduate students and early career researchers working on industry-focused translational research projects.
There were many significant developments globally relating small modular reactor technologies technologies in the latter half of 2020.
Minerals Principal Consultant, Dr Karin Soldenhoff, was honoured with the 2024 NSW Women in Mining -Technological Innovation award last week for her work as technical lead on the Australia Strategic Metals (ASM) Dubbo Project, and development of a new solvent extraction technology to separate rare earth and other critical elements.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.